Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial.

Annals of Internal Medicine
Robert A SchnollCaryn Lerman

Abstract

Tobacco dependence is a chronic, relapsing condition that may require extended treatment. To assess whether extended-duration transdermal nicotine therapy increases abstinence from tobacco more than standard-duration therapy in adult smokers. Parallel randomized, placebo-controlled trial from September 2004 to February 2008. Participants and all research personnel except the database manager were blinded to randomization. (ClinicalTrials.gov registration number: NCT00364156) Academic center. 568 adult smokers. In an unstratified small block-randomization scheme, participants were randomly assigned to standard therapy (Nicoderm CQ [GlaxoSmithKline, Research Triangle Park, North Carolina], 21 mg, for 8 weeks and placebo for 16 weeks) or extended therapy (Nicoderm CQ, 21 mg, for 24 weeks). The primary outcome was biochemically confirmed point-prevalence abstinence at weeks 24 and 52. Secondary outcomes were continuous and prolonged abstinence, lapse and recovery events, cost per additional quitter, and side effects and adherence. At week 24, extended therapy produced higher rates of point-prevalence abstinence (31.6% vs. 20.3%; odds ratio, 1.81 [95% CI, 1.23 to 2.66]; P = 0.002), prolonged abstinence (41.5% vs. 26.9%; odds ratio, ...Continue Reading

References

Oct 1, 1992·Journal of Consulting and Clinical Psychology·J R Hughes
Sep 1, 1991·British Journal of Addiction·T F HeathertonK O Fagerström
Mar 18, 1999·Drug and Alcohol Dependence·A I AltermanA Cnaan
Jun 22, 2000·Health Economics·D F Heitjan
May 25, 2002·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·UNKNOWN SRNT Subcommittee on Biochemical Verification
Sep 7, 2002·JAMA : the Journal of the American Medical Association·John P Pierce, Elizabeth A Gilpin
Oct 9, 2002·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Fujian SongNerys Woolacott
May 15, 2003·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·John R HughesGary E Swan
Jan 30, 2004·The American Journal of Medicine·Neal L Benowitz
Oct 30, 2004·The American Journal of Psychiatry·Sharon M HallJennifer Cullen
Apr 1, 2005·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Maansi A BansalGary A Giovino
Jul 23, 2005·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·E Paul WileytoCaryn Lerman
May 3, 2006·Journal of Consulting and Clinical Psychology·Saul ShiffmanDuncan B Clark
Jul 6, 2006·JAMA : the Journal of the American Medical Association·David GonzalesUNKNOWN Varenicline Phase 3 Study Group
Jul 6, 2006·JAMA : the Journal of the American Medical Association·Douglas E JorenbyUNKNOWN Varenicline Phase 3 Study Group
Sep 19, 2006·American Journal of Preventive Medicine·Melissa R PartinAnne M Joseph
Dec 13, 2006·Addiction·Saul ShiffmanMark Balabanis
Jan 27, 2007·The Cochrane Database of Systematic Reviews·J R HughesT Lancaster
Feb 3, 2007·Pharmacology, Biochemistry, and Behavior·Dorothy HatsukamiStephen Hecht
Feb 7, 2008·The Cochrane Database of Systematic Reviews·L F SteadT Lancaster
Jul 2, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Jed E RoseEric C Westman

❮ Previous
Next ❯

Citations

Sep 24, 2013·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Richard A BrownLawrence H Price
Jun 13, 2014·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Lisa M FucitoUNKNOWN Writing Committee for the SRNT Policy and Treatment Networks
Sep 4, 2013·Molecular Psychiatry·J R TurnerJ A Blendy
Sep 3, 2011·Journal of Oncology Practice·Glen MorganLisa Sanderson Cox
Apr 23, 2013·Cancer Causes & Control : CCC·Robert A SchnollTracey Evans
Sep 13, 2013·International Journal of Environmental Research and Public Health·Sharon Lawn, Jonathan Campion
Jan 27, 2011·Current Treatment Options in Cardiovascular Medicine·Elizabeth V Ratchford, James H Black
May 17, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Robert A SchnollNeal L Benowitz
Aug 16, 2013·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Raka JainRobert A Schnoll
Jul 6, 2010·Cardiovascular Drugs and Therapy·John J McNeilLisa L Ioannides-Demos
May 15, 2015·The New England Journal of Medicine·Scott D HalpernKevin G Volpp
Nov 14, 2015·Health Technology Assessment : HTA·Fiona DobbieLinda Bauld
Apr 14, 2016·Addictive Behaviors·William G ShadelJoan S Tucker
Jan 10, 2013·Annual Review of Clinical Psychology·Tanya R Schlam, Timothy B Baker
Sep 25, 2016·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Lion ShahabLinda Bauld
Feb 28, 2017·Addiction·Jennifer R LaudeSean P David
Mar 10, 2011·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Mary FalconeRiju Ray
Mar 1, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Allison B GoldCaryn Lerman
Dec 19, 2012·The Pharmacogenomics Journal·R L AshareC Lerman
Jun 1, 2018·The Cochrane Database of Systematic Reviews·Jamie Hartmann-BoyceTim Lancaster
Jan 20, 2012·The Cochrane Database of Systematic Reviews·Amanda C FarleyPaul Aveyard
Apr 19, 2019·The Cochrane Database of Systematic Reviews·Nicola LindsonJamie Hartmann-Boyce
Oct 18, 2011·Current Atherosclerosis Reports·J Taylor HaysJon O Ebbert
Jul 9, 2014·Australian Health Review : a Publication of the Australian Hospital Association·Sharon LawnAdrian Keller
Sep 15, 2018·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Allison J CarrollBrian Hitsman
Jul 15, 2020·American Journal of Respiratory and Critical Care Medicine·Frank T LeoneHarold J Farber
Dec 19, 2019·AIDS Care·Su Fen LubitzRobert Schnoll
Nov 16, 2012·The Cochrane Database of Systematic Reviews·Lindsay F SteadTim Lancaster
Jun 24, 2017·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Nandita KrishnanJonathan E Golub
May 25, 2016·Psycho-oncology·Sarah PriceRobert Schnoll
May 30, 2017·Journal of Smoking Cessation·Rebecca L AshareRobert A Schnoll
Oct 28, 2015·Addiction·Shane Darke, Michael Farrell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.